Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells

Oncogene

Volumn 19, Issue 15, 2000, Pages 1924-1932

  Ren, Fengge ^a   Zhang, Shaobo ^a   Mitchell, Susan H ^a   Butler, Rachel ^a   Young, Charles Y F ^a  

^a MAYO CLINIC   (United States)

Author keywords

Androgen receptor; Human glandular kallikrein; Prostate specific antigen; Sp1; Tea polyphenols; Theaflavins

Indexed keywords

ANDROGEN RECEPTOR; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GALLOCATECHIN; MESSENGER RNA; POLYPHENOL; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING SITE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA TRANSFECTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN DNA BINDING; RECEPTOR DOWN REGULATION; RECEPTOR GENE; TEA; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0034611606     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203511     Document Type: Article

References (51)

1. Ahmad N, Feyes DK, Nieminen A-L, Agarwal R and Mukhlar H. (1997). J. Natl. Cancer I., 89, 1881-1886.
2. Alroy I, Soussan L, Seger R and Yarden Y. (1999). Mol. Cell. Biol., 19, 1961-1972.
3. Andrews PE, Young CYF, Montgomery BT and Tindall DJ. (1992). Cancer Res., 52, 1525-1529.
4. Blok LJ, de Ruiter PE and Brikmann AO. (1996). Endocr. Res., 22, 197-219.
5. Blok LJ, de Ruiter PE and Brikmann AO. (1998). Biochemistry, 37, 3850-3857.
6. Blot WJ, Chow WH and McLaughlin JK. (1996). Eur. J. Cancer Prev., 5, 425-438.
7. Brawer MK and Ellis WJ. (1995). Cancer, 75, 1783-1789.
8. Charlesworth MC, Young CYF, Klee GG, Saedi MS, Mikolajczyk SD, Finlay JA and Tindall DJ. (1997). Urology, 49, 487-493.
9. Chen S, Supakar PC, Vellanoweth RL, Song CS, Chatterjee B and Roy AK. (1997). Mol. Endocrinol., 11, 3-15.
10. Chomazynski P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
11. Culig Z, Hobisch A, Hittmair A, Peterziel H, Cato ACB, Barisch G and Klocker H. (1998). The Prostate, 35, 63-70.
12. Darson MF, Pacelli A, Roche P, Rittenhouse HG, Wolfen RL, Young CYF, Klee GG, Tindall DJ and Bostwick DG. (1997). Urology, 49, 857-862.
13. Dorgan JF, Judd JT, Longcope C, Schatzkin A, Clevidence BA, Campbell WS, Nair PP, Franz C, Kahle L and Taylor PR. (1996). Am. J. Clin. Nutrition, 64, 850-855.
14. Feigl P, Blumenstein B, Thompson I, Crovvley J, Wolf M, Kramer BS, Coltman Jr CA, Rrawley OW and Ford LG. (1995). Control. Clin. Trials, 16, 150-163.
15. Fleshner NE and Traehtenberg J. (1995). J. Urol., 154, 1642-1646.
16. Gann PH, Hennekens CH, Ma J, Longcope C and Stampfer MJ. (1996). J. Natl. Cancer I., 88, 1118-1126.
17. Gregory CW, Hamil KG, Hall SH, Pretlow TG, Mohler JL and French FS. (1998). Cancer Res., 58, 5718-5724.
18. Gupta S, Ahmad N, Mohan RR, Husain MM and Mukhtar H. (1999). Cancer Res., 59, 2115-2120.
19. Hamalainen E, Adlercreutz H, Puska P and Pietinen P. (1984). J. Steroid Biochem., 20, 459-464.
20. Hsieh M-L, Charlesworth MC, Goodmanson M, Zhang S, Seay T, Klee GG, Tindall DJ and Young CYF. (1997). Cancer Res., 57, 2651-2656.
21. Huggins C and Hodges CV. (1941). Cancer Res., 1, 293-297.
22. Kaisary AV, Tyrrell CJ, Beacock C, Lunglmayr G and Debruyne F. (1995). Eur. Urol., 28, 215-222.
23. Kemppainen JA, Lane MV, Sar M and Wislon EM. (1992). J. Biol. Chem., 267, 968-974.
24. Kemppainen JA and Wilson EM. (1996). Urology, 48, 157-163.
25. Koivisto P, Kolmer M, Visakorpi T and Kallioniemi OP. (1998). Am. J. Pathol., 152, 1-9.
26. Koivisto P, Kononen J, Palmberg C, Tammela T, Hyytinen E, Isola J, Trapman J, Cleutjens K, Noordzij A, Visakorpi T and Kallioniemi OP. (1997). Cancer Res., 57, 314-319.
27. Koivisto P, Visakorpi T and Kallioniemi OP. (1996). Scand. J. Clin. Lab. Invest., 56, 57-64.
28. Krongrad A, Wilson CM, Allman DR and McPaul MJ. (1991). Mol. Cell. Endocrinol., 76, 79-88.
29. Labrie F, Bclangcr A, Dupont A, Luu-The V, Simard J and Labrie C. (1993). Clin. Invest. Med., 16, 475-492.
30. Liao S and Hiipakka RA. (1995). Biochem. Biophysl. Res. Comm., 214, 833-838.
31. Liao S, Umekita Y, Guo J, Kokontis JM and Hiipakka RA. (1995). Cancer Lett., 96, 239-243.
32. Lindzey J, Kumar MV, Grossmann M, Young CYF and Tindall J. (1994). Vitam. Horm., 49, 383-432.
33. Mizokami A and Chang C. (1994). J. Biol. Chem., 269, 25655-25659.
34. Montgomery BT, Young CYF, Bilhartz DL, Andrews PE, Prescott JL, Thompson NF and Tindall DJ. (1992). The Prostate, 21, 63-73.
35. Paschka AG, Butler R and Young CYF. (1998). Cancer Lett., 130, 1-7.
36. Philipsen S and Suske G. (1997). Nucleic Acids Res., 27, 2991-3000.
37. Pienta KJ and Esper PS. (1993). Ann. Intern. Med., 118, 793-803.
38. Ryu SJ, Zhou S, Ladurner AG and Tjian R. (1999). Nature, 397, 446-450.
39. Soloway M Sand Matzkin H. (1993). Cancer, 71, 1083-1088.
40. Spitzweg C, Zhang S, Bergen ER, Castro MR, Mclver B, Heufelder AE, Tindall DJ, Young CYF and Morris JC. (1999). Cancer Res., 59, 2136-2141.
41. Stoner GD and Mukhtar H. (1995). J. Cell. Biol. Chem., S22, 169-180.
42. Takane KK and McPhaul MJ. (1996). Mol. Cell. Endocrinol., 119, 83-93.
43. Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN and Balk SP. (1995). New Engl. J. Med., 332, 1393-1398.
44. Thompson L, Feigl P and Coltman C. (1995). Important Advances in Oncology: Chemoprevention of Prostate Cancer with Finasteride. De Vita Jr VT, Hellman S and Rosenberg SA. (eds). JB Lippincott Company: Philadelphia, pp. 57-76.
45. Trapman J and Cleutjens KBJM. (1997). Semin. Cancer Biol., 8, 29-36.
46. Van laar JH, Berrevoets CA, Trapman J, Zegers ND and Brinkmann AO. (1991). J. Biol. Chem., 266, 3734-3738.
47. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Palotie A, Tammela T, Isola J and Kallioniemi OP. (1995). Nature Genetics, 9, 401-406.
48. Zhang S, Hsieh M-L, Zhu W, Klee GG, Tindall DJ and Young CYF. (1999). Endocrinology, 140, 1665-1671.
49. Zhang S, Murtha PE and Young CYF. (1997a). Biochem. Biophysl. Res. Comm., 231, 784-788.
50. Zhang J, Zhang S, Murtha PE, Zhu W, Hou SS and Young CYF. (1997b). Nucleic Acids Res., 25, 3143-3150.
51. Zhou ZX, Lane MV, Kemppainen JA, French FC and Wilson EM. (1995). Mol. Endocrinol., 9, 208-218.